Diabetic retinopathy, a leading cause of vision loss affecting millions, damages the retina's blood vessels. Experts ...

West Bengal mirrors the national crisis but with sharper disparities between urban and rural regions. In a large, multi-district study screening 1,553 diabetics across 14 districts, DR prevalence was ...

Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.

Aviceda Therapeutics ("the Company" or "Aviceda"), a clinical-stage biotechnology company developing innovative therapies for retinal diseases, today announced topline results from its SIGLEC Phase 2b ...

The Cuban comedian Ulises Toirac provided an update on his health status on Thursday, delivering it with his signature mix of ...

Eli Lilly and Company has finalized its acquisition of Adverum Biotechnologies, a move that delivers a promising gene therapy ...

Aviceda Therapeutics has released topline results from its phase 2b study, SIGLEC, evaluating AVD-104 in patients with ...

In diabetic macular edema, faricimab can improve visual acuity for treatment-naïve eyes or sustain vision for those ...

In this video from the American Academy of Ophthalmology meeting, Michael W. Stewart, MD, discussed results from the phase 2 DAVIO 2 trial on Duravyu in neovascular age-related macular ...

The quickly-binding biologic lonigutamab demonstrated initial success in improving signs and symptoms of thyroid eye disease ...

Kaleb Abbott, OD, explains his research into the use of botox injections to treat friction-related, eyelid-associated ocular ...

Anti-VEGF therapy for patients with retinopathy of prematurity reduces myopia compared with laser treatments, but comes with other risks.